期刊文献+

经颈静脉肝内门体静脉分流术操作技术与围手术期安全性分析 被引量:11

Analysis of technique and perioperative safety of transjugular intrahepatic porto-systemic shunt
原文传递
导出
摘要 目的评价经颈静脉肝内门体静脉分流(TIPS)术的操作技术与围手术期安全性。方法回顾分析1126例接受TIPS术治疗肝硬化门静脉高压者的临床资料。患者中男732例、女394例,平均年龄为46.4岁。术前排除消化性溃疡及其他可能引起出血的疾病,择期手术患者适当调整其凝血功能和血小板数量。穿刺颈静脉,造影显示肝静脉及下腔静脉情况,穿刺门静脉并造影,栓塞曲张静脉,球囊扩张分流通道,置人支架。术后予常规观察并予抗凝治疗和随访。计量资料比较行t检验。结果TIPS术成功率为98.6%(1110/1126),其中择期手术成功率为98.8%(997/1009),急诊手术成功率为96.6%(113/117),平均门静脉压力由术前的(3.89±0.73)kPa降至术后的(2.61±0.63)kPa,差异有统计学意义(t=44.23,P〈0.05)。经肝静脉建立分流通道者957例,经肝段下腔静脉建立分流通道者130例,同一患者建立2个TIPS分流通道者23例。栓塞曲张静脉981例。145例联用经皮肝穿刺门静脉术或联用胃冠状静脉栓塞术。总病死率为0.6%(7/1110),其中择期手术病死率为0.4%(4/997),急诊手术病死率为2.7%(3/113)。严重并发症发生率为2.0%(22/1110),其中择期手术严重并发症发生率为1.8%(18/997),急诊手术严重并发症发生率为3.5%(4/113)。随访6、12、24个月时的症状复发率分别为7.8%(65/831)、17.3%(132/763)、26.6%(175/657),分流道再狭窄率分别为8.5%(71/8311)、23.5%(179/763)、32.0%(210/657),生存率分别为98.0%(814/831)、95.4%(728/763)、89.6%(589/657)。结论TIPS术前做好充分准备、术中谨慎操作、术后细致观察病情并及时处理,可提高成功率,降低风险。 Objective To evaluate the technique and perioperative safety of transjugular intrahepatic porto systemic shunt (TIPS). Methods The clinical data of 1126 liver cirrhosis and portal hypertension patients received TIPS treatment were retrospectively analyzed. Among all the patients, male 732 cases, female 394 cases, the mean age was 46. 4 years. The jugular vein was punctured and the condition of hepatic vein and the inferior vena cava was showed by angiography. The portal vein was punctured and angiographied, varices veins were embolized. The tract was dilated by the balloon and stent was set. After treatment, regular observation, anticoagulant therapy and follow- up were carried out. Comparison t test was performed for measurement data. Results The over all successful rate of TIPS was 98. 6% (1110/1126), in which the successful rate of elective operation was 98.8% (997/1009) and the successful rate of emergency operation was 96.6% (113/117). The average portal vein pressure decreased from (3.89±0.73) kPa before operation to (2.61±0.63) kPa after operation, and the difference was statistically significant (t=44.23, P〈0.05). The tracts was created in 957 cases through hepatic vein, 130 cases through inferior vena cava,and 23 cases with two TIPS tracts. Varices veins were embolized in 981 cases. A total of 145 cases had combined percutaneous transhepatic portography. The overall mortality rate was 0.6 % (7/1110), in which the mortality rate of elective operation was 0.4% (4/997) and the mortality rate of emergency operation was 2. 7% (3/113). The severe complication rate was 2. 0% (22/1110), of elective operation accounted for 1.8% (18/1009) and emergency operation accounted for 3. 5% (4/113). After six-month,12 month and 24-month follow up, the recurrence rate was 7.8% (65/831), 17.3% (132/ 763) and 26.6,0/oo (175/657);restenosis rate was 8. 5% (71/831), 23. 5% (179/763) and 32. 0% (210/657) ;and the survival rate was 98.0% (814/831), 95.4% (728/763) and 89.6% (589/657). Conclusion The successful rate of TIPS can be increased and the risk reduced by full preparation before operation, careful manipulation during operation, meticulous observation and timely treatment after operation.
出处 《中华消化杂志》 CAS CSCD 北大核心 2013年第5期331-335,共5页 Chinese Journal of Digestion
关键词 肝硬化 高血压 门静脉 门体分流术 外科 围手术期医护 Liver cirrhosis Hypertension, portal Portasystemic shunt, surgical Perioperative care
  • 相关文献

参考文献10

  • 1祁兴顺,韩国宏,樊代明.经颈静脉肝内门体分流术治疗门静脉血栓的现状[J].介入放射学杂志,2010,19(11):916-920. 被引量:8
  • 2Dhanasekaran R,West JK,Gonzales PC,et al. Transjugularintrahepatic portosystemic shunt for symptomatic refractoryhepatic hydrothorax in patients with cirrhosis. Am JGastroenterol.2010,105 :635-641.
  • 3Darwish Murad S,Plessier A, Hcrnandez-Guerra M, et al.Etiology . management, and outcome of the Budd-Chiarisyndrome. Ann Intern Med, 2009,151 : 167-175.
  • 4Chevallier P, Novelli L, Motamedi JP, et al.Hepatopulmonary syndrome successfully treated withtransjugular intrahepatic portosystemic shunt: a three-yearfollow-up. J Vase Interv Radiol, 2004,15 : 647-648.
  • 5Han G,Qi X,He C,et al. Transjugular intrahepaticportosystemic shunt for portal vein thrombosis withsymptomatic portal hypertension in liver cirrhosis. JHepatol, 20U ,54:78-88.
  • 6Goykhman Y,Ben-Haim M, Rosen G,et al. Transjugularintrahepatic portosystemic shunt : current indication's,patient selection and results. Isr Med Assoc J , 2010,12 :687-691.
  • 7Gazzera C,Righi D, Valle F, et al. Fifteen years, experiencewith iransjugular intrahepatic portosystemic shunt (TIPS)using bare stents : retrospective review of clinical andtechnical aspects. Radiol MecJ, 2009,114 : 83-94.
  • 8Surendrababu NR, Keshava SN, Eapen CE, et al.Transjugular intrahepatic portocaval shunt placed throughthe strut of an inferior vena cava stent in a patient with Budd-Chiari syndrome: a technical modification. Br J Radiol,2010,83:e22-e24.
  • 9Kurmis TP. Transjugular intrahepatic portosystemic shunt :an analysis of outcomes. ANZ J Surg, 2009 ,79 : 745-749.
  • 10Dr Amico G,Luca A,Morabito A,et al. Uncoverediransjugular intrahepatic portosystemic shunt for refractoryascitcs : a meta-analysis. Gastroenterology, 2005,129 :1282-1293.

二级参考文献5

共引文献7

同被引文献128

  • 1孙鑫国,邓小军,刘旭云,段诗姣,谢卫华,鄢琼,张宏文.PTVE治疗门静脉高压性上消化道出血的特殊并发症及处理措施的探讨[J].临床放射学杂志,2020,39(5):974-978. 被引量:5
  • 2Romaric Loffroy,Louis Estivalet,Violaine Cherblanc,Sylvain Favelier,Pierre Pottecher,Samia Hamza,Anne Minello,Patrick Hillon,Pierre Thouant,Pierre-Henri Lefevre,Denis Krausé,Jean-Pierre Cercueil.Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage[J].World Journal of Gastroenterology,2013,19(37):6131-6143. 被引量:25
  • 3张渝红,陈睿.Tipss术后肝性脑病1例报告[J].贵阳医学院学报,2001,26(4):375-375. 被引量:1
  • 4方文,刘振生,邓钢,何仕成,郭金和,朱光宇,李国昭,滕皋军.经皮脾穿刺CO_2门静脉造影与动脉法间接门静脉造影的对照研究[J].中华放射学杂志,2005,39(12):1308-1311. 被引量:5
  • 5BERZIGOTI'IA, GARCIA-PAGAN J C.Prevention of recu- rrent variceal bleeding [J]. Dig Liver Dis, 2008,40 (5) : 337-342.
  • 6SAAD W E,DARWISH W M, DAVIES M G,et al. Trans- jugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites:clinical outcome [J]. J Vase Interv Radiol, 2010, 21 (2):218- 223.
  • 7BOYER T D,HENDERSON J M,HEEREY A M,et al. Cost of preventing variceal rebleeding with transjugular intrahepatie portal systemic shunt and distal splenorenal shunt[J]. J Hepatol,2008,48(3):407-414.
  • 8Lauermann J, Potthoff A, Mc Cavert M, et al. Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stent- graft Device [ J ]. Cardiovasc Intervent Radiol, 2016,39 (4) : 547- 556. DOI : 10. 1007/s00270-015-1209-x.
  • 9Citron SJ. Re: "Portal Vein Recanalization-Transjugular Intrahe- patic Portosystemic Shunt Using the Transsplenic Approach to Achieve Transplant Candidacy in Patients with Chronic Portal Vein Thrombosis" [J].J Vasc Interv Radiol, 2015,26 ( 11 ) : 1750. DOI:10. 1016/j. jvir. 2015.07. 015.
  • 10Salem R, Vouche M, Baker T, et al. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis [ J ]. Transplantation,2015,99 ( 11 ) : 2347-2355. DOI: 10. 1097/TP. 0000000000000729.

引证文献11

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部